| 1. |
Herman, A., Kappler, J. W., Marrack, P., and Pullen, A. M. (1991) Super antigens: mechanism of T-cell stimulation and role
in immune responses. Annu. Rev. Immunol.
9, 745–772.
|
| |
| 2. |
Testi, R., Pulcinelli, F., Frati, L., Gazzaniga, P. P., and Santoni, A. (1990) CD69 is expressed on platelets and mediates
platelet activa-tion and aggregation. J. Exp. Med.
172, 701–707.
|
| |
| 3. |
Sutkowski, N., Palkama, T., Ciurli, C., Sekaly, R. P., Thorley-Lawson, D. A., and Huber, B. T. (1996) An Epstein-Barr virus-asso-ciated
superantigen. J. Exp. Med.
184, 971–980.
|
| |
| 4. |
Waller, E. K., Sen-Majumdar, A., Kamel, O. W., Hansteen, G. A., Schick, M. R., and Weissman, I. L. (1992) Human T-cell development
in SCID-hu mice: staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy. Blood
80, 3144–3156.
|
| |
| 5. |
Baribaud, F., Wirth, S., Maillard, I., Valsesia, S., Acha-Orbea, H., and Diggelmann, H. (2001) Identification of key amino
acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
J. Virol.
75, 7453–7461.
|
| |
| 6. |
Melchers, F., Potter, M., and Warner, N. L. (1978) Lymphocyte hybridomas. Second workshop on "e;functional properties
of tumors of T and B lymphocytes."e; Preface. Curr. Top. Microbiol. Immunol.
81, IX–XXIII.
|
| |
| 7. |
Kouttab, N., Tannir, N., Pathak, S., Berger, A., Sahasrabuddhe, C. G., and Maizel, A. L. (1985) Establishment of stable human
T-T hybridomas. J. Immunol. Methods
77, 165–172.
<Occurrence Type="DOI"><Handle>10.1016/0022-1759(85)90194-2</Handle></Occurrence>
|
| |
| 8. |
Choi, Y. W., Herman, A., DiGiusto, D., Wade, T., Marrack, P., and Kappler, J. (1990) Residues of the variable region of the
T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature
346, 471–473.
|
| |
| 9. |
Kappler, J. W., Skidmore, B., White, J., and Marrack, P. (1981) Antigen-inducible, H-2-restricted, interleukin-2-producing
T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med.
153, 1198–1214.
|
| |
| 10. |
Norcross, M. A., Bentley, D. M., Margulies, D. H., and Germain, R. N. (1984) Membrane Ia expression and antigen-presenting
accessory cell function of L cells transfected with class II major histocompatibility complex genes. J. Exp. Med.
160, 1316–1337.
|
| |
| 11. |
Mix, D. and Winslow, G. (1996) Proteolytic processing activates a viral superantigen. J. Exp. Med.
184, 1549–1554.
|
| |
| 12. |
Conlon, P. J. (1983) A rapid biologic assay for the detection of interleukin 1. J. Immunol.
131, 1280–1282.
|
| |
| 13. |
Hori, T., Uchiyama, T., Tsudo, M., Umadome, H., Ohno, H., Fukuhara, S., et al. (1987) Establishment of an interleukin 2-depen-dent
human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma
virus. Blood
70, 1069–1072.
|
| |
| 14. |
Beutner, U., Rudy, C., and Huber, B. T. (1992) Molecular characterization of Mls-1. Int. Rev. Immunol.
8, 279–288.
|
| |
| 15. |
Sutkowski, N., Conrad, B., Thorley-Lawson, D. A., and Huber, B. T. (2001) Epstein-Barr virus transactivates the human edogenous
retro virus HERV-K18 that encodes a superantigen. Immunity
15, 579–589.
<Occurrence Type="DOI"><Handle>10.1016/S1074-7613(01)00210-2</Handle></Occurrence>
|
| |
| 16. |
Staufer, Y., Marguerat, S., Meylan, F., Ucla, C., Sutkowski, N., Huber, B. T., Pelet, T., and Conrad, B. (2001) Interferon-α
induced endogenous superantigen: a model link between the environment and autoimmunity. Immunity
15, 591–601.
<Occurrence Type="DOI"><Handle>10.1016/S1074-7613(01)00212-6</Handle></Occurrence>
|
| |